We are live on ! Find out more
AVXL icon

Anavex Life Sciences

149 hedge funds and large institutions have $383M invested in Anavex Life Sciences in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more capital inflows, than outflows

Capital inflows: $56.7M | Capital outflows: $29.4M

59% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 32

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

26% more call options, than puts

Call options by funds: $19.2M | Put options by funds: $15.2M

10% more funds holding

Funds holding: 136 → 149 (+13)

1.86% more ownership

Funds ownership: 27.22% → 29.08% (+1.9%)

Holders
149
Holders Change
+13
Holders Change %
+9.56%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
51
Reduced
32
Closed
18
Calls
$19.2​M
Puts
$15.2​M
Net Calls
+$4.02​M
Net Calls Change
+$3.18​M

AVXL Hedge Fund Activity: Q4 2021 in Review

149 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2021, worth a combined $383M — up 3.6% from $370M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new AVXL positions and 18 closed out — a net gain of 8 holders — while 51 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $15.8M. The largest seller was State Street, cutting an estimated $6.3M.

  • 149 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2021, up from 136 in Q3 2021.
  • Funds reported $383M of Anavex Life Sciences stock for Q4 2021, up 3.6% quarter-over-quarter.
  • 26 funds opened new Anavex Life Sciences positions in Q4 2021 and 18 closed out, a net change of +8 holders.
  • The largest Anavex Life Sciences buyer in Q4 2021 was BlackRock, an estimated $15.8M added.
  • The largest Anavex Life Sciences seller in Q4 2021 was State Street, an estimated $6.3M sold.

Based on aggregated 13F filings for Q4 2021.